![Kenneth Lynard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Lynard
Director Financiero/CFO en
PHARMING GROUP N.V.
.
Perfil
Kenneth Lynard currently works at Zentiva SA, as Non-Executive Director from 2019, Zentiva as (Slovakia), as Member-Supervisory Board from 2020, and Pharming Group NV, as Chief Financial Officer from 2025.
Mr. Lynard also formerly worked at Affidea Group BV, as Group Chief Financial Officer & Managing Director from 2017 to 2019, Gilead Sciences, Inc., as Chief Financial Officer from 2012 to 2016, Medtronic Plc, as CFO-Europe, Middle East & Africa, Schoeller Allibert Group BV, as Chief Financial Officer, and Zentiva Group as, as Chief Financial Officer.
Mr. Lynard received his graduate degree from Copenhagen Business School and Masters Business Admin degree from International Institute for Management Development.
Últimas noticias acerca de Kenneth Lynard
Cargos activos de Kenneth Lynard
| Empresas | Cargo | Inicio |
|---|---|---|
| ZENTIVA S.A. | Director/Miembro de la Junta | 01/10/2019 |
| ZENTIVA, | Director/Miembro de la Junta | 15/11/2020 |
| PHARMING GROUP N.V. | Director Financiero/CFO | 01/10/2025 |
Antiguos cargos conocidos de Kenneth Lynard.
| Empresas | Cargo | Fin |
|---|---|---|
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Director Financiero/CFO | 01/01/2019 |
| GILEAD SCIENCES, INC. | Director Financiero/CFO | 01/01/2016 |
Schoeller Allibert Group BV
 Schoeller Allibert Group BV Industrial MachineryProducer Manufacturing Designs, develops, manufactures and supplies industrial returnable transit packaging solutions | Director Financiero/CFO | - |
Zentiva Group as
 Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Director Financiero/CFO | - |
| MEDTRONIC PLC | Director Financiero/CFO | - |
Formación de Kenneth Lynard.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
26
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
Affidea Group BV
Affidea Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Zentiva as (Slovakia)
 Zentiva as (Slovakia) Pharmaceuticals: GenericHealth Technology Develops, manufactures, and sells generic pharmaceutical products | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentiva SA
 Zentiva SA Pharmaceuticals: MajorHealth Technology Manufactures miscellaneous pharmaceuticals | Health Technology |
Medtronic Plc
 Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Schoeller Allibert Group BV
Schoeller Allibert Group BV Industrial MachineryProducer Manufacturing Designs, develops, manufactures and supplies industrial returnable transit packaging solutions | Producer Manufacturing |
- Bolsa de valores
- Insiders
- Kenneth Lynard
